• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The waning effect of postmenopausal estrogen therapy on osteoporosis.

作者信息

Ettinger B, Grady D

出版信息

N Engl J Med. 1993 Oct 14;329(16):1192-3. doi: 10.1056/NEJM199310143291610.

DOI:10.1056/NEJM199310143291610
PMID:8377785
Abstract
摘要

相似文献

1
The waning effect of postmenopausal estrogen therapy on osteoporosis.
N Engl J Med. 1993 Oct 14;329(16):1192-3. doi: 10.1056/NEJM199310143291610.
2
Prevention, diagnosis, and management of osteoporosis-related fracture.
J Am Osteopath Assoc. 2009 Mar;109(3):191-3.
3
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理：北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
4
[The effect of hormone replacement therapy on bone mineral content and on fractures].[激素替代疗法对骨矿物质含量及骨折的影响]
Ugeskr Laeger. 1997 Jan 27;159(5):570-6.
5
[The Medical Products Agency on prevention of osteoporosis: estrogen reduces the risk of fractures in certain women].
Lakartidningen. 1994 Jan 5;91(1-2):58-60.
6
Osteoporosis: prevention with estrogens in women over 60.骨质疏松症：60岁以上女性雌激素预防法
Maturitas. 1999 Sep 24;33(1):1-6.
7
Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?绝经后女性接受雌激素/孕激素治疗是否会降低其骨折风险？
J Fam Pract. 2001 Nov;50(11):926.
8
[Bones are breaking without estrogen].没有雌激素，骨骼就会断裂。
Duodecim. 2003;119(22):2183-9.
9
Prevention and treatment of osteoporosis with hormone replacement therapy.激素替代疗法防治骨质疏松症
Int J Fertil Menopausal Stud. 1993;38 Suppl 1:45-54.
10
Prevention of osteoporosis is still a valid aim for hormone therapy.预防骨质疏松症仍然是激素治疗的一个有效目标。
Climacteric. 2005 Jun;8(2):97-8. doi: 10.1080/13697130500165911.

引用本文的文献

1
The Sequential Therapy in Osteoporosis.骨质疏松症的序贯治疗
Indian J Orthop. 2023 Dec 9;57(Suppl 1):150-162. doi: 10.1007/s43465-023-01067-2. eCollection 2023 Dec.
2
The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence.骨质疏松症序贯和联合治疗的理由和方法。对当前证据的回顾。
Arch Endocrinol Metab. 2022 Nov 11;66(5):724-738. doi: 10.20945/2359-3997000000564.
3
The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.抗骨质疏松药物停药后的下一步：序贯治疗的最新综述。
Endocrine. 2019 Jun;64(3):441-455. doi: 10.1007/s12020-019-01919-8. Epub 2019 Apr 8.
4
Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial.地诺单抗停用与相关骨折发生率：来自骨质疏松症中地诺单抗每6个月降低骨折评估（FREEDOM）试验的分析。
J Bone Miner Res. 2013 Apr;28(4):746-52. doi: 10.1002/jbmr.1808.
5
Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.大规模激素替代疗法与预期寿命：欧洲和北美人群国际比较结果
Am J Public Health. 2000 Sep;90(9):1397-402. doi: 10.2105/ajph.90.9.1397.
6
Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.激素替代疗法：II. 对其在预防绝经后骨质疏松症和缺血性心脏病中作用的药物经济学评估。
Pharmacoeconomics. 1994 Jun;5(6):513-54. doi: 10.2165/00019053-199405060-00007.
7
Bone mineral density measurements: are they worth while?骨密度测量：它们值得吗？
J R Soc Med. 1996 Aug;89(8):457-61. doi: 10.1177/014107689608900810.
8
Hormone replacement therapy in the aged. A state of the art review.
Drugs Aging. 1996 Mar;8(3):193-213. doi: 10.2165/00002512-199608030-00005.
9
Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.预防。有多大危害？有多大益处？2. 确定益处临床意义时的十个潜在陷阱。
CMAJ. 1996 Jun 15;154(12):1837-43.
10
Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing.卫生部搬起石头砸自己的脚。为何骨质疏松咨询小组的报告破坏了循证采购原则。
BMJ. 1996 Feb 3;312(7026):296-7. doi: 10.1136/bmj.312.7026.296.